Table 1.
Participants’ characteristics
| Participant 1 | Participant 2 | Participant 3 | Participant 4 | |
|---|---|---|---|---|
| Age (category) | 45–55 | 45–55 | 45–55 | 45–55 |
| Gender | Female | Female | Female | Female |
| Months since cancer diagnosis | 26 | 10 | 37 | 28 |
| Months since end of acute medical treatment | 20 | 3 | 31 | 27 |
| Cancer diagnosis | Breast cancer | Endometrial cancer | Breast cancer | Breast cancer |
| Cancer Treatment | Chemotherapy, radiotherapy | Surgery, chemotherapy | Mastectomy, chemotherapy | Mastectomy |
| Adjuvant cancer treatment | None | None | Tamoxifen | Tamoxifen, zoladex |
| Relationship Status | Married | Married | Married | Married |
| Employment Status | Retired | Employed part time | Employed full time | Employed full time |
| Referrer | General practitioner | Clinical nurse specialist | Clinical oncologist | Clinical oncologist |
| Previous psychological treatment | CBT | None | CBT, counselling | None |
| Current psychotropic medication | Citalopram | Citalopram | None | None |
| Current psychiatric diagnosis | GAD, MDD | None | GAD | GAD |
CBT cognitive behaviour therapy, GAD generalized anxiety disorder, MDD major depressive disorder